News
18h
TipRanks on MSNRigel Pharmaceuticals reports Q2 EPS $3.91, consensus $1.40Reports Q2 revenue $101.7M, consensus $72.58M. Total revenue and net income are inclusive of $40M in non-cash contract revenue related to Rigel’s ...
Viatris (VTRS) is set to announce Q2 earnings amid EPS and revenue declines. Learn about its recent trials, stock dip, and Wall Street's Hold rating.
Key Points Non-GAAP operating earnings per share for Q2 2025 exceeded analysts' expectations, but Headline revenue and non-GAAP earnings declined significantly from the prior year. A transformative ...
Key Points GAAP earnings per share and revenue missed analyst expectations for Q2 2025 and declined from the prior year. Gross margin (GAAP) improved by 1.7 percentage points in Q2 2025 compared to ...
12hon MSN
Spirit AeroSystems reported 1.6 billion in revenue for the second quarter of 2025, driven by increased production of Boeing ...
The company put up a bottom-line revenue that not only exceeded Wall Street expectations, but also its own history of ...
Palantir shows strong growth, but lofty expectations, stretched valuation, and unrealistic EPS forecasts create downside risk ...
18h
TipRanks on MSNAmgen reports Q2 adjusted EPS $6.02, consensus $5.28Reports Q2 revenue $9.2B, consensus $8.91B. “We’re delivering strong performance and reaching more patients with innovative medicines and ...
U.S. commercial revenue skyrocketed 93% year over year on phenomenal demand for the company's artificial intelligence ...
The Meta company (formerly Facebook) has released its earnings results for the most recent quarter, and Q2 2025 looked like ...
UnitedHealth Group ( NYSE: UNH) reported stronger-than-expected earnings for the second quarter of 2025, with adjusted ...
Teledyne Technologies (TDY -1.69%), a global leader in digital imaging, instrumentation, and aerospace and defense ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results